Dr. med. Melanie Hagen



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma (2025) Müller F, Schwingen NR, Hagen M, Scholz J, Aigner M, Wirsching A, Taubmann J, et al. Journal article Harnessing the potential of CAR-T cell in lupus treatment: From theory to practice (2024) Alsuliman T, Marjanovic Z, Rimar D, Tarte K, Avcin T, Hagen M, Schett G, Farge D Journal article, Review article Treatment of CNS systemic lupus erythematosus with CD19 CAR T cells (2024) Hagen M, Müller F, Wirsching A, Kharboutli S, Spörl S, Aigner M, Völkl S, et al. Journal article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article Bispecific T cell engager therapy for refractory rheumatoid arthritis (2024) Bucci L, Hagen M, Rothe T, Raimondo MG, Fagni F, Tur C, Wirsching A, et al. Journal article BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease. (2024) Hagen M, Bucci L, Böltz S, Nöthling DM, Rothe T, Anoshkin K, Raimondo MG, et al. Journal article, Letter CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article CAR-T-Zell-Therapie in der Rheumatologie – Was wissen wir bisher? (2024) Hagen M, Wirsching A, Bohr D, Taubmann J, Müller F, Mackensen A, Grieshaber Bouyer R, Schett G Journal article Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial (2024) Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schönau V, Hueber A, et al. Journal article